Protocol to Validate the Performance of the Mellitus Glycated CD59 ELISA for Gestational Diabetes Screening

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

May 31, 2019

Primary Completion Date

May 31, 2020

Study Completion Date

September 30, 2020

Conditions
Gestational Diabetes
Interventions
DIAGNOSTIC_TEST

Mellitus GCD59 Test

An ELISA for screening for the risk of gestational diabetes

Trial Locations (19)

19104

University of Pennsylvania, Philadelphia

19713

Christina Care Health System, Newark

21287

Johns Hopkins University, Baltimore

23507

Eastern Virginia Medical School, Norfolk

27599

University of North Carolina, Chapel Hill, Chapel Hill

29605

Greenville Health System, Greenville

35294

University of Alabama, Birmingham

43209

Ohio State University School of Medicine, Columbus

44109

MetroHealth Medical Center, Cleveland

49503

Spectrum Hleath, Grand Rapids

77401

Baylor College of Medicine, Houston

77555

University of Texas Medical Branch, Galveston

78207

University of Texas Health Science Center, San Antonio, San Antonio

78758

Austin Maternal-Fetal Medicine, Austin

80045

University of Colorado Anschutz Medical Campus, Aurora

84132

University of Utah School of Medicine, Salt Lake City

92868

UC Irvine Health, Orange

02118

Boston Medical Center, Boston

01605

UMass Medical School/UMass Memorial Health Care, Worcester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Regulatory and Clinical Research Institute Inc

OTHER

lead

Mellitus, LLC

INDUSTRY